These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26400025)

  • 1. Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response.
    Hiratsuka I; Itoh M; Yamada H; Yamamoto K; Tomatsu E; Makino M; Hashimoto S; Suzuki A
    Endocr J; 2015; 62(12):1059-66. PubMed ID: 26400025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating chemokines in patients with autoimmune thyroid diseases.
    Domberg J; Liu C; Papewalis C; Pfleger C; Xu K; Willenberg HS; Hermsen D; Scherbaum WA; Schloot NC; Schott M
    Horm Metab Res; 2008 Jun; 40(6):416-21. PubMed ID: 18415893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.
    Cakir M; Levendoglu F; Kiyici A; Coskun Y
    Autoimmunity; 2011 Sep; 44(6):496-503. PubMed ID: 21457060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
    Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy.
    Gu X; Zheng L; Chen X; Ruan L; Zhang H; Ge S; Zhu H; Lin X; Shen F
    Horm Metab Res; 2012 Jun; 44(6):482-7. PubMed ID: 22473756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
    Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
    Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease].
    Zhang JA; Zhang J; Xu L; Mar H; Wu XY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):630-2. PubMed ID: 16948912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.
    Song RH; Yu ZY; Qin Q; Wang X; Muhali FS; Shi LF; Jiang WJ; Xiao L; Li DF; Zhang JA
    Int J Clin Exp Pathol; 2014; 7(7):4024-31. PubMed ID: 25120780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases.
    Cheng CW; Wu CZ; Tang KT; Fang WF; Lin JD
    Autoimmunity; 2020 Aug; 53(5):261-269. PubMed ID: 32338082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs in autoimmune thyroid diseases.
    Yamada H; Itoh M; Hiratsuka I; Hashimoto S
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):276-81. PubMed ID: 24533739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
    Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
    Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
    Myśliwiec J; Okota M; Nikołajuk A; Górska M
    Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Romagnani P; Grosso M; Ferrannini E; Serio M
    Eur J Endocrinol; 2006 May; 154(5):651-8. PubMed ID: 16645011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased differentiation of Th22 cells in Hashimoto's thyroiditis.
    Bai X; Sun J; Wang W; Shan Z; Zheng H; Li Y; Zhao Y; Gong M; Teng W
    Endocr J; 2014; 61(12):1181-90. PubMed ID: 25242258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of integrin α4β1 and α4β7 on B cells correlates with autoimmune responses in Graves' disease.
    Zhao R; Gu J; Zhao H; Wang Z; Liu X; Yuan C; Zheng X; Yang T; Xu X; Cai Y
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113218. PubMed ID: 39317053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
    Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
    Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated interleukin-1β in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis.
    Sun L; Zhang X; Dai F; Shen J; Ren C; Zuo C; Zhang Q
    Endocr Res; 2016 Aug; 41(3):185-92. PubMed ID: 26864865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.